Effects of Acute Intake of Flavanols on Cerebral Oxygenation and Cognition in Young Male Adults
NCT ID: NCT04374409
Last Updated: 2020-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2018-10-02
2018-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Cocoa Flavanols on Pulmonary Oxygen Uptake Kinetics and Exercise Tolerance in Sedentary Middle-aged Adults
NCT04370353
Cocoa Flavanol Intake and Exercise in Hypoxia
NCT03135314
High Flavonols Cocoa Intake for the Improvement of Body Fat Composition in Athletes
NCT04028128
Effects of Cocoa Flavanols on Human Cognitive Function
NCT01344551
The Vascular and Cognitive Effects of Chronic High-flavanol Intake in Healthy Males
NCT02789761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-flavanol Cocoa powder
Dietary supplement: single serving of a high-flavanol cocoa powder containing 150 mg of (-)-epicatechin and 35.5 mg of (+)-catechin
High-flavanol cocoa powder
Non-alkalized fat-reduced cocoa powder (Natural Acticoa)
Low-flavanol Cocoa powder
Dietary supplement: single serving of a low-flavanol cocoa powder intervention containing \< 4 mg of (-)-epicatechin and (+)-catechin and matched as best as possible for macronutrients and micronutrients, such as caffeine and theobromine.
Low-flavanol cocoa powder
Alkalized fat-reduced cocoa powder (10/12 DDP Royal Dutch)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High-flavanol cocoa powder
Non-alkalized fat-reduced cocoa powder (Natural Acticoa)
Low-flavanol cocoa powder
Alkalized fat-reduced cocoa powder (10/12 DDP Royal Dutch)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-45 years old
Exclusion Criteria
* hypertensive
* with history of cerebrovascular, cardiovascular or respiratory disease
* allergies or intolerances to ingredients present in cocoa powders
* taking long-term medication (e.g., hyperlipidaemia)
* on antibiotics for the previous 3 months before enrollment
* suffering from blood-clotting disorders
* known infections at the time of the study
* on a weight-reducing regimen
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Illinois at Urbana-Champaign
OTHER
University of Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Catarina Rendeiro
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catarina Rendeiro, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Sport, Exercise & Rehabilitation Sciences, University of Birmingham
Birmingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERN_17_1591
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.